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Abstract
Depression is one of the leading causes of disease and disability, often found in patients with
long-term chronic physical conditions such as diabetes. Collaborative care, which includes care
managers, has shown to improve depression outcomes in patients; usual care has been shown to
be inadequate. This quality improvement project screened patients with diabetes for depression.
Patients with an elevated depression screening score were provided care management support
and rescreened every two weeks to evaluate depression symptoms. A small cohort of patients
from two rural health clinics participated in the improvement project. The practices noted
improvement in depression screening; patients who participated and received care management
services had an overall improvement in Patient Health Questionnaire-9 (PHQ-9) scores and
glycated hemoglobin (A1c) rates over the project period. The practice findings indicated that
focusing on improved systems for rural health clinic patients with diabetes and depression may
impact health outcomes, however, additional work needs to be done to determine sustainability
in rural health clinics beyond the quality improvement project period. The quality improvement
project limitations included study design and size.
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Introduction
Problem Description
Depression is the second leading cause of disability worldwide affecting one in five
United States adults over the course of a lifetime (Acee, 2015; Moussavi et al., 2007). Increasing
with age and co-morbidities, the rate of depression doubles in people with diabetes (Acee, 2015).
Sixty-eight percent of patients with mental illness have a medical condition leading to functional
impairments that result in an inability to adhere to healthy lifestyle choices, for example,
maintaining a balanced diet, exercising or taking required medications (Moussavi et al., 2007).
Despite widespread evidence supporting the benefits of depression screening and updated 2016
United States Preventive Task Force (USPTF), depression screening recommendations that
standardize screening until remission or reduction of symptoms are often not conducted (Siu et
al., 2016).
Studies have demonstrated that “usual care” for depression has resulted in only half of
depressed adults receiving treatment in the United States (Kessler RC, Chiu W, Demler O, &
Walters EE, 2005). The term “usual care” means that patients diagnosed with depression are
treated by their primary care providers and no additional organizational modifications are made
within the context of treatment. Patients may receive medication and/or a referral to specialty
behavioral health care practices, however, the coordination, advocacy and knowledge acquisition
of the services are the responsibility of the patient (Coventry et al., 2012; Kessler RC et al.,
2005; Trangle et al., 2016). Depression care is more often reactive versus proactive in nature.
IJff et al., (2007) found that only 20% to 40% of depressed adults showed improvement after
twelve months of receiving usual care. Evidence-based treatments are available; however, they
are adopted sporadically often due to knowledge, cost, operational obstacles, and workforce
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shortages. Strategies that merely focus on guideline implementation have been shown to be
ineffective compared to clinician education with enhanced care management roles (Gilbody S,
Whitty P, Grimshaw J, & Thomas R, 2003). Detection of depression in patients is complicated
by physical disease, often leading to a poor treatment and response (Iosifescu et al., 2003).
Barriers to treatment are magnified by the time-limited nature of primary care encounters, the
prioritization of competing needs, limited access to services and lack of evidence-based
standardize guideline implementation (Gilbody et al., 2003). New Hampshire’s experience with
diagnosing and treating depression reflects national trends (New Hampshire Citizens Health
Initiative, 2016). For the better part of the last two decades, behavioral health care in New
Hampshire has often been fragmented, episodic and poorly coordinated (Cherokee Health
Systems, 2014). Patients have been unable to navigate timely care for prevention and treatment
of chronic illness. Workforce shortages, gaps in health information technology, lack of the full
adoption of standardized evidence-based clinical care guidelines and deficient person-centered
systems have further delayed appropriate care within the state.
Currently, New Hampshire ranks 17th nationally per capita for mental health expenditures
and 9th for overall health care expenditures (“Mental Health Spending,” 2018; “Health Care
Expenditures per Capita by State of Residence,” 2017). New Hampshire has a large proportion
of rural communities that have limited access to services (Appendix A) (“Rural and Non Rural
Public Health Regional Networks 2017/2018,” 2017). Nationally, rural locations with lower
socioeconomic status (Table 1) have a disproportionate share of residents reporting symptoms of
depression (Dittrich et al., 2015). The New Hampshire Accountable Care Learning Network used
claims data and reported that over 40% of under age 65 members had depression or anxiety and a
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chronic condition, the number rose to 80% in the Medicare population (New Hampshire Citizens
Health Initiative, 2016).
Table 1. United States adults with current depression by Socioeconomic Status 2006
Behavioral Risk Factor Surveillance System (BRFSS) Data

Variable

Geographic Locale

Factors

Socioeconomic Status
% Lower SES

% Middle SES

% High SES

Non-Rural

55.0

37.7

7.3

Rural

65.6

31.1

3.3

Several large-scale efforts have brought together New Hampshire’s health care
community and key stakeholders including insurers, federal, state and local government,
businesses, patients and families to improve patient care. The first, a landmark class action
settlement agreement allowed for the implementation of new services for the severe and
persistently mentally ill (SPMI). The second, on January 5th, 2016 the Centers for Medicare and
Medicaid Services (CMS) approved New Hampshire’s section 1115(a) Medicaid demonstration
entitled Building Capacity for Transformation, a Delivery System Reform Incentive Payment
(DSRIP). The NH DSRIP demonstration aimed “to transform the way physical and behavioral
health care are delivered to Medicaid beneficiaries with behavioral health disorders, and/or
substance use disorders (SUDs) and/or substance misuse” (New Hampshire Department of
Health and Human Services, 2017, p. 3). Finally, the New Hampshire Behavioral Health
Integration Learning Collaborative (BHI Learning Collaborative), a project of the New
Hampshire Citizens Health Initiative Accountable Care Learning Network (NHACLN)
developed by New Hampshire Citizens Health Initiative (NHCHI) brought together more than 60
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organizations since 2015. The focus of this collaboration was behavioral health integration in
primary care and payment reform. Providers of all types and specialties, including all of the
state’s community mental health centers, major private and public insurers, and government
worked together to learn and share best practices. As part of these key efforts, standardized
evidence-based depression treatment algorithms were identified and shared. Despite these
efforts consistent depression screening and treatment varies widely. Where depression screening
has been conducted, few efforts have been successfully undertaken to link care management
efforts to improved patient outcomes.
Given the significance of depression and diabetes, two New Hampshire Rural Health
Clinics (RHCs) were recruited to participate in a quality improvement (QI) project focused on
depression screening and treatment. Table 2 describes the number of patients at the practice with
diabetes and the county prevalence (“NH Health Wisdom,” n.d.). Although both practices
screened patients for depression during annual exams, based on patient complaint or clinical
judgement, neither practice had a standardized workflow that incorporated care management and
rescreening for patients with diabetes or documentation that included the use of a registry. Both
RHCs varied in their clinical staff and operational design which reflected the variation seen
across the state in practice type. One practice included behavioral health within their health care
system; the other relied predominately on referrals to access behavioral services.
Table 2. Number of Patients with Diabetes by Practice and County Prevalence

Percent Adult
2015 County
Patients
Diabetes as
Diagnosed with
Percent of
Diabetes
Population
Practice A
n/a
7.40
Practice B
9.2
7.97
Note: Practice A was unable to determine accurate prevalence
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Available Knowledge
A systematic search strategy was used to assess the available knowledge regarding
diabetic patients identified with depression within the primary care setting who were offered care
management services based on depression screening results. The search terms included:
diabetes, depression, nurse, primary care, care management, screening, and collaborative care.
The search was comprised of electronic databases, limited to adult human subjects between 2000
to August 2017 and written in English. The following journal article searches resulted in:
CINAHL (1), Cochrane Library (5), Medline (2), PsychINFO (2), PubMed (5), Trip Medical
Database (5) and ProQuest (20). A total of seven databases were reviewed, which included grey
literature, and resulted in 30 journal articles. After the articles were reviewed for inclusion
criteria and evaluated for bias, three non-duplicative research based randomized control trials
were identified.
The studies were conducted in the United States, Canada and Australia at primary care
clinics (Johnson et al., 2012; Katon et al., 2010; Morgan et al., 2013). Katon et al., (2010) was
constructed as a single blinded randomized control and was of the highest quality. The study in
Austria and Canada attempted to replicate Katon’s et al., (2010) findings. Morgan et al., (2013)
had a two-arm open randomized cluster trial with wait-list control for 6 months. Johnson et al.,
(2014) design was the weakest in terms of bias with two control groups and active control and a
usual control group. All three studies were 12 months long. An important note is that the
Australian and Canadian studies were subsequent to the published Katon et al., (2010) study and
attempted to replicate the intervention. All three studies differed slightly in methodology. The
structure of the study was impacted by the practice, resources and settings. All studies
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monitored depression and diabetes outcomes using an evidence-based tool. Katon et al., (2010)
used the Symptom Checklist-20 (SCL-20) to measure depression outcomes. The control group
had a statistically significant decrease at 12 months (0.40 points, P<0.001) in depression
symptoms using the Symptom Checklist–20 (SCL-20). The Australian study (Morgan et al.,
2013) showed mean depression scores after 6 months of intervention for patients with moderateto-severe depression decreased by 5.7±1.3 compared with 4.3±1.2 in control, a significant
(p=0.012) difference with a 95% confidence range. Johnson et al., (2014) found that intervention
patients had greater 12-month improvements in PHQ-9 (7.3[SD5.6]) compared with control
subjects (5.2[SD5.7], P= 0.015). Recovery of depressive symptoms (i.e., PHQ-9 reduced by
50%) was greater among the intervention group (61%vs.44%, P=0.03). Compared with trial
patients, non-screened control subjects had significantly less improvement at 12 months in the
PHQ score (3.2 [SD 4.9]) and lower rates of recovery (24%, P < 0.05 for both). Only one study,
reported statistically significant changes in the glycated hemoglobin level (Katon et al., 2010).
Rationale
The quality improvement project was based on the framework of the Expanded Chronic
Care Model (CCM) originally developed in the 1990’s by Edward Wagner, Director Emeritus,
MacColl Center for Health Care Innovation (Figure 1) and revised in 2003 (Barr et al., 2003;
Bodenheimer, Wagner, & Grumbach, 2002). CCM has long been used to provide a framework
for considering how to deliver population and patient level care. CCM is aligned with behavioral
health integration within primary care. The CCM model can be used to address macro, meso and
micro changes in the delivery of health care for patients with depression and improve overall
outcomes. Using the model, screening and rescreening can be implemented with adequate
systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up
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while remaining patient centered and developing scalable care management solutions. Treatment
and follow-up would include diagnosis, patient engagement and education based on the nature of
the disease, risks and benefits of treatment and patient preference. In the CCM model ongoing
contacts would be systematic and include documented encounters over the first 12 months of
care (schedules appointments, phone calls, portal interactions, etc.) including documented
tracking of treatment and response (O’Conner, E., Rossom, R.C., Henninger, M., Groom, H.C.,
Burda, B.U., Henderson, J.T., Bigler, K. D., & Whitlock, E. P., 2016).
Figure 1. The Expanded Chronic Care Model
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Specific Aims
The QI project’s workflow modifications are based upon evidence that supports moving
towards improved patient outcomes via an evidence-based systematic screening and rescreening
for depression and structured biweekly proactive care management and outreach. The PHQ-9
(Appendix B) is one of the most highly regarded screening tools for depression. The quality
improvement project established a standardized evidence-based screening workflow in rural
health clinics to evaluate, treat and track treatment response in diabetes patients with PHQ-9
scores that are >=10.
Appropriate and reasonable treatment and follow-up would include diagnosis, patient
engagement and education based on the nature of the disease, risks and benefits of treatment and
patient preference. Specifically, each practice:

1. Established the level of behavioral health integration.
2. Established the baseline depression screening rate in patients with diabetes.
3. Developed an evidence-based clincal workflow and a pathway for patients identified
as depressed.
4. Initiated comprehensive treatment planning with a care managment component in
patients with diabetes and a PHQ-9 score ≥10.
5. Bi-weekly rescreening of patients with the PHQ-9 to determine response to treatment.
6. Tracked care management activities as part of the clincal workflow
7. Captured and aggregated physical health metrics (HbA1c, blood pressure and body
mass index) at baseline and each health care incounter to determine response to
treatment.
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Methods

Context
The quality improvement interventions took place at two rural health clinic practices
located within New Hampshire. Practice A was independently owned, Practice B was part of a
critical access hospital system. The practices employed primary care providers (medical doctors,
doctors of osteopathy, nurse practitioners and physician assistants). Both practices had been
actively engaged in national or state-wide quality improvement efforts focused on improving the
care for chronically ill patients. Each practice utilized an electronic health record (EHR) to
document, track, record results and develop treatment plans. Practice team composition varied.
A recommended core team at the RHC included at least one provider, a behavioral health
clinician (if employed at the practice), a nurse, a care manager (if different from the nurse), a
data analyst, and leadership.
Interventions
To be included in the intervention, adult (18 years of age and older) patients who
presented for a diabetes follow-up appointment, were screened using the PHQ-9. Patients that
had a PHQ-9 ≥ 10 were asked if they were willing to participate in the quality improvement
project and receive additional care management services. A signed informed patient consent was
required prior to participation (Appendix C).
Each practice followed a defined standardized evidence-based depression screening
protocol (Figure 2) (Trangle et al., 2016). Study participants with a PHQ-9 ≥ 10, mild, moderate
or severe depression had a person-centered individualized care plan developed. The care plan
may have included depression management with antidepressants and/or psychotherapy, diabetes
management including Diabetes Self-Management Evaluation (DSME) classes, stepped
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care/treat-to-target algorithms and/or lifestyle modifications (Trangle et al., 2016). Every two
weeks the patient was contacted and rescreened with the PHQ-9, this occurred at an office visit
or during telephone follow-up calls. The PHQ-9 screening was done by the provider, care
management nurse or behavioral health clinician. Treatment adjustments were made in
collaboration with the care team, individualized care plan modified as deemed necessary.
Figure 2. Collaborative Care Interventions for Patients with Diabetes and Depression
Screening and Rescreening Protocol

The proposed timeline was 6 months, with a goal of getting a minimum of three months
of data for each participant to measure response to the intervention. The frequency of data
submission to the researcher was to occur monthly. Although data was reported monthly, the
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PHQ-9 was conducted every two weeks for each participant enrolled for a total of 6 times if the
participant was in the study for three months.
Each practice took a baseline analysis using the Site Self-Assessment (SSA) (Appendix
D), an instrument that measures the level of behavioral health integration occurring within a
practice (Scheirer, Leonard, Ronan, & Boober, 2015). Based on the SSA results, practices were
asked to track care management services, registry development, self-management support, teambased care, team huddles, staff training as part of the quality improvement framework and
process. Each practice was provided a standardized evidence-based workflow from the Institute
for Clinical Systems Improvement of Adult Depression in Primary Care guidelines (Trangle et
al., 2016). The practice staff were asked to review the nursing job descriptions for the key staff
that would be involved in providing care management interventions.
Study Interventions
The Model for Improvement, is a widely used framework for accelerating system change
within health care organizations (Berwick, 1996). The model consists of setting aims,
establishing measures, selecting change ideas and conducting tests of change (Figure 3).
The model provided a framework for the iterative quality improvement process undertaken to
target practice level and patient level improvement (Taylor et al., 2014). Corresponding changes
were made using Plan-Do-Study-Act (PDSA) cycles. Focused learning occurred during each
cycle. The Plan for this quality improvement project was to screen adult patients for depression
who presented for diabetes follow-ups using a defined standardized evidence-based workflow.
All patents who had a PHQ-9 ≥ 10 were offered care management services. The Do was to
provide the patients structured care management services and proactive follow-up. Every two
weeks the practices Studied the patients’ PHQ-9 results to evaluate the care management
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component at that practice level (Figure 3). Modifications were made to the process during the
Act phase to include adoption or abandonment.

Figure 3. Model for Improvement

Measures
Each practice began the quality improvement work reviewing their current level of
behavioral health integration by completing a baseline Site Self-Assessment (SSA). The practice
was asked to take the SSA as a team and discuss the answers to each question and come to a
consensus. Each dimension or question is based on a 1-10 scale. Usual care is indicated by a
score of 1, and a fully transformed practice would score a 10. There are 18 questions with a
minimum score of 18 and maximum score of 180. The SSA is the approved tool measuring
behavioral health integration throughout NH. The tool has also been used widely throughout the

12

DEPRESSION SCREENING, DIABETES and CARE MANAGEMENT
United States. The format of the Site Self-Assessment instrument is based on the format of the
Assessment of Primary Care Resources and Supports for Chronic Disease Self-Management
(PCRS) developed by the Diabetes Initiative of the Robert Wood Johnson Foundation (Brownson
et al., 2007). The SSA is used by primary care teams to evaluate the current delivery system
practices and identify quality improvement opportunities. The SSA consists of two domains;
Integrated Services for the Patient and Family and Organizational Supports and 18 dimensions
(Scheirer et al., 2015).
As part of the assessment, current state of depression screening and follow-up was
evaluated at the practice level. Each practice was provided a standardized evidence-based
workflow that utilized the Institute for Clinical Systems Improvement for Adult Depression in
Primary Care guidelines (Trangle et al., 2016). The practice staff were asked to review the
nursing job descriptions for the key people that would be involved in providing collaborative
care interventions. For intervention participants, all data was de-identified, information was
collected on blood pressure, body mass index (BMI), hemoglobin A1C and screening for
depression using the PHQ-9, care management and education activities. A variety of instruments
can be utilized to screen for depression. In primary care settings, the PHQ-2 and the PHQ-9 are
the most widely used depression screening tools in the United States. A recent study found that
only 5% of patients with an elevated PHQ-2 were screened with the PHQ-9 (Fuchs et al., 2015).
The PHQ-9 is a valid instrument for depression detection and monitoring in primary care
settings. Further, it has been validated for measurement depression severity (Kroenke, 2010;
Spitzer, 1999). It has a sensitivity (false negative) of 0.77 and specificity (false positive) of 0.85
when using the screened item scoring method (Trangle et al., 2016). Many practices diagnose a
patient as depressed following a positive PHQ-9 however, a rescreening is often not performed
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to determine if the condition has improved following treatment. Presumably, patients and staff
would benefit from a structured workflow based on results of screening and rescreening which
would trigger treatment recommendations. Patients with diabetes identified with depression had
individualized treatment plans developed and received follow-up by the health care team based
on a standardized protocol. The practice used and/or developed shared decisions aids and flow
charts.
Analysis
IBM® SPSS Statistical Software was used for data analysis and descriptive statistics. The
sample size was too small for hypothesis testing.
Ethical Considerations
Each practice signed a letter of commitment (LOC) outlining project activities and
requirements (Appendix E). The University of New Hampshire’s Institutional Review Board for
the Protection of Human Subjects in Research (IRB) reviewed and approved the protocol as
described in Title 45, Code of Federal Regulations (CFR), Part 46, and Subsection 110
(Appendix F). Minimal risks were identified regarding participation in the QI project. One
identified risk was that an individual would be identified as suicidal during the evidence-based
depression screening.
As with any research or quality improvement project, the participants were made aware
both verbally and via a written consent form that there may not be any direct benefits to patients
from study participation. At an organizational level, the practice established the organization’s
stage of behavioral health integration and clinical outcomes, and identified areas for quality
improvement. The outcome of this research was provided to the practice, if the data was shared
it would be done so in aggregate.
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Results
Practice A team members included one provider, a nurse practitioner and new nurse care
manager and data analyst (Table 3). Practice A had limited behavioral health services which
focused predominantly on providing substance use disorder treatment. The nurse, functioned as
the care manager at the practice and followed-up with the patient’s bi-weekly.
Practice B included a nurse who was to provide care management, three primary care
providers and a master’s prepared social worker who provided generalist behavioral health
services. The social worker was based at the hospital and made regular visits to the practice
based on need. The social worker provided extensive care management plan development and
was responsible for bi-weekly patient follow-up.
Both RHC practices experienced staffing interruptions that impacted the intervention
team during the October-April time frame. Team members were either replaced or diverted to
cover clinic areas that were experiencing staffing shortages. Practice Team A had one consistent
team member, a nurse practitioner who was also the QI director. The QI director functioned in
the leadership role. Prior to the start of the project the behavioral health clinician left the practice
and the position was not replaced, the data analyst retired and a new individual was trained and
began working on the project at month four. A new nurse care manager was hired and dedicated
to chronic care management four hours per week. Practice B did not have staffing changes in the
practice team during the improvement effort (November through April). However, Practice B
did experience attrition in other positions which impacted the nurse care management function.
Further, Practice B did relocate to the main hospital for a short period while remodeling
occurred. All patients were seen at the temporary hospital location approximately 20 minutes
from the original RHC location. Throughout the project, Practice A had weekly quality
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improvement meetings at the practice and the work was incorporated into the standard QI
meetings. Practice B held a brief training for all clinical staff to discuss the evidence behind the
project, the new screening algorithm and care management services. Following the initial kick
off session, Practice B had monthly meetings held at the main hospital.
Table 3. Practice Team Composition

Practice
A
B

Providers
Nursing
NPac
RN de
NPb, DOb, PA b
RNa e

Behavioral
Health

IT
Data Analyst be

LICSWac

Data Analyst b

a

Primary team member
Support team member
c
Team member present for entire project
d
Team member addition mid project
e
Workforce changes during project
Nurse practitioner (NP)
Registered Nurse (RN)
Doctor of Osteopathy (DO)
Physician’s Assistant (PA)
Licensed Social Worker (LICSW)
b

Prior to implementing the intervention, each practice took the SSA. Practice A took the
SSA as a team and discussed the answers to both domains and all 18 questions. Practice B had
one individual take the SSA. The results were 57/180 for Practice A and 147/180 for Practice B.
Three months after baseline the practices retook the SSA, Practice A’s results improved by 93%
and Practice B improved by 12.2% (Table 4). Both practices took the follow-up SSA as a team
and discussed their responses. The overall percent difference over baseline for both practices
combined was 80.8%. The SSA dimension “data system records” was the only dimension that
had an overall percent decrease due to Practice A’s -37.5% change over baseline. Practice B had
only one dimension with a decrease which was “follow-up assessment and treatment referral” by
10%. The largest increases in SSA scores were in the dimensions “patient care based on best
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practice evidence”, “communication with patients about integrated care” and “continuity of
care”. The largest changes, over 100%, were attributed to Practice A, which at the beginning of
the project did not have care management services, developed pathways for behavioral health
referral, a registry, or clinical algorithms embedded in the EHR. For Practice B, which had a
drop in behavioral health services at the RHC practice, the largest gain was in the dimension of
“treatment planning” at 27.5%. Both practices had increases in the dimension “practice team”,
an increase of 600% for Practice A and 12.5% for Practice B.
Figure 4. Quality Improvement Timeline and Improvement Ramp
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Table 4. Comparison between Private and Hospital Based RHC Site Self-Assessment
Results
Site Self-Assessment Dimension

Practice A
(%)

Practice B
(%)

Level of Integration
Screening and Assessment
Treatment Plans
Patient Care Based on Best Practice Evidence
Patient and Family Involvement
Communication with Patient about Integrated Care
Follow up assessment – Treatment Referral
Social Support
Linking to Community Resources
Organizational Leadership for Integrated Care
Patient Care Team
Providers Engagement with Integrated Care
Continuity of Care (PCP and BMH)
Coordination of Referral and Specialists
Data System Records
Patient and Input to Integration Management
Staff Education and Training for Integrated Care
Funding Sources and Resources
Total Score: Site Self-Assessment

0.0
100.0
66.6
300.0
50.0
300.0
200.0
40.0
75.0
33.0
600.0
75.0
600.0
150.0
37.5
300.0
100.0
150.0
93.0

0.0
0.0
27.5
0.0
14.3
0.0
10.0
0.0
0.0
0.0
12.5
11.1
0.0
11.1
11.1
14.3
12.5
0.0
12.2

Difference
Between
Practice A
and
Practice B
(%)
0.0
100.0
39.1
300.0
35.7
300.0
210.0
40.0
75.0
33.0
587.5
63.9
600
161.1
48.6
285.7
87.5
150.0
80.8

At baseline, neither practice could identify a standardized written protocol consistently
used to screened for depression and rescreen for response with a structured care management and
follow-up component (Appendix G-I). Each practice did have an annual depression screening
protocol; however, Practice A did not have a discrete data field in the EHR to capture responses.
Pre- and post- QI adult diabetes screening rates can be found in Table 5.

Table 5. Adult Patients Diabetes Patients Screened for Depression

Quarter 2 2017

Quarter 1 2018
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Baseline
n
#
screened

Follow-up
Screening n
Rate

#
screened

Screening
Rate

Practice A
PHQ-9
286
0
0%
279
97
27%
Practice B
PHQ-9
143
73
51%
141
79
56%
Note: Data was pulled using electronic health records reports, if screening was not in a discrete
data field, the result was not captured

Table 6. Baseline and Follow-up Patient Outcome Comparisons

Baseline
n
M
Practice A
A1c
4
8.93
PHQ-9
4
15.25
Practice B
A1c
4
7.90
PHQ-9
4
16.7500
Practice A and Practice B
A1c
8
8.41
PHQ-9
8
16.00
n=sample size
M=mean
SD = standard deviation
A1c = Hemoglobin A1c
PHQ-9=Patient Health Questionnaire

Follow-up
n

Difference
Mean

4
4

7.55
8.25

1.38
7.00

2
4

7.40
12.25

0.50
4.50

6
8

7.50
10.25

0.91
5.75

Further, each practice identified gaps in their protocol for suicidal ideation/suicide risk identified
in the PHQ-9 screening, which prompted further review and modification. One site provided
additional training for all staff on managing patients at risk for suicide and providing immediate
assistance.
The QI project timeline was fairly aggressive, and both practices were slow to identify
patients that had a PHQ-9 ≥ 10. Practice A reported that patients were reluctant to sign the
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consent form. Eight patients, four from each practice participated long enough to have a baseline
PHQ-9 and four follow-up screenings and care management appointments. The overall mean
A1c and PHQ-9 scores when patients were aggregated across practices reduced from 8.41 to 7.50
and 16.00 to 10.25 respectively. Analyzing each practice independently, each practice had a
decline in mean A1c and PHQ-9 scores. Practice A, the practice with the lowest baseline SSA
score at baseline, reported more improvement in both mean A1c and PHQ-9 scores over
baseline.
Qualitative information was captured as part of the quality improvement project.
Patients provided formal feedback regarding the care management initiative. A patient who
recently achieved sobriety during the QI project period commented, “It is nice to be called to see
how you are”. The care management activities allowed for reinforcement of relapse prevention
strategies and continued encouragement to continue with psychiatry visits and perhaps insightorientated therapy. During the course of the study, the patients PHQ-9 decreased from a baseline
score of 15 to 6. Another patient commented, “I would not have made this much progress if I
did not have the extra help”. Several of the patients who participated had depression, diabetes
and substance use disorders. Further, at least two of the patients had family members that had
recently committed suicide.
Staff feedback was positive, one staff member commented, “I cannot believe the
improvement in the health outcomes; however, it takes time to do this work and often we are
short staffed”. Behavioral health staff providing counseling and care management stated that,
“Providers did not fully appreciate what I could bring to the table until we started this QI
project”. All QI team members in both practices reported improvement in communication
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between the provider-patient and clinical staff regardless of position. Both practices also noted
that the EHR was at times a barrier to collect population health data and required time.
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Discussion
Summary
The QI project’s aim and workflow modifications were based upon evidence that
supports moving towards improved patient outcomes via an evidence-based systematic screening
and rescreening for depression and structured biweekly proactive care management and outreach.
Each RHC practice moved towards the adoption of the evidence-based depression screening
guidelines focused on targeting patients with diabetes for the QI project. The QI project results
cannot be extrapolated due to the small sample size and limited time-frame. The findings are
important at the practice level and within the population of the practice. Further, the individual
work spent with each patient began to identify community resources and support services that
were needed to address exercise, social isolation, cost of extracurricular activities and
transportation.
Utilizing an interdisciplinary team, each practice sought to advance the incorporation of
evidence-based knowledge and treatment in depressed patients with diabetes. The engagement
of the RHC’s in the quality improvement activities provided immediate evaluation of each
practice’s delivery care setting and responsiveness to patients diagnosed and treatment of
depression. The SSA results were used as an inventory of focused areas to improve chronic care
management and aligned with Barr et al., (2003) Expanded CCM. Specifically, the care
management supported the individual’s development of enhanced life skills by identifying
patient’s readiness for change, and linked them with community resources. Biweekly patient
contacts allowed for PHQ-9 rescreening with the patient and individualized care management
modification. The focused and consistent use of the PHQ-9 at the care management in-person
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visits or phone contacts made each RHC contemplate patient specific results. Further, staff felt a
great sense of pride in the ability to see rapid improvements with patients.
Initially, the practices had some degree of concern regarding the PHQ-9 question (9)
related to suicide or harm to others. Both practices adopted education and policy modifications
to education staff members regarding suicide prevention and established protocols as it relates to
community support to treat at risk patients needing additional services.
Interpretation
The RHC’s reported improvements in multiple SSA dimensions indicating that the
practice team taking the SSA noted changes in the dimension during the QI periods. Four
dimensions that both practices improved were the use of treatment plans, patient and family
involvement in care, the use of patient care teams and provider engagement. By the end of the
project period, the inter-professional teams had developed a system to evaluate the service
delivery at the patient level by using care management plans. The use of data to capture
population changes remained a challenge. Although each practice was able to obtain population
data, it was a struggle. The dimension “data system records” was the only area where an overall
decrease was noted when the outcomes of both practices were combined.
The overall SSA score for both practices increased, indicating that core components of
behavioral integration advanced during the QI period. Practice A had a large increase in the
screening rate and self-reported SSA dimension “screening and assessment” over the QI period.
The SSA score for Practice B, the practice reported higher levels of overall integration and the
use of screening instruments for patients with behavioral health conditions had no change in the
SSA dimension for screening and minor increases in the screening rate, this practice reported a
very small increase in screening patients with diabetes. This indicates that the new workflow has
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not been fully adopted, which likely impacted the number of patients identified with a PHQ-9
≥10. Aggregate PHQ-9 scores and A1c decreased for both practices, similar to the findings in
the research-based literature.
Large scale research studies have demonstrated improved outcomes that are similar to the
small sample improvements that the RHC clinics experienced. Dissemination and scalability is
often undermined by a scarcity of resources, competing demands and professional resistance
(Coventry et al., 2012). Time and staffing impacted the practice’s ability to collect and monitor
population base data, specifically, the “study” component of the PDSA was a challenge and
impacted the formation of rapid recommendations to improve outcomes. As a result, cycles were
prolonged as workforce shortages continued throughout the QI period.
Limitations
The QI project was very small; randomization did not occur and there was no comparison
group. A major strength of the SSA is that it comes directly from the practice, that said,
response bias contributes to measurement error. Study enrollment was triggered by a patient
with diabetes filling out a PHQ-9 at an office visit which can result in selection of a particular
group of patients. For example, would severely depressed patients be motivated to present for a
diabetes follow-up visit and take the PHQ-9? Additionally, low patient response rates may
select for certain patient characteristics. Further, a developing detailed training plan for the
nursing care management role was part of the QI effort; additional work needs to be done to
explore the specific items related to care management that were effective making replication
difficult without additional PDSA cycles and data collection.
Conclusions
Improved systems for patients with chronic care is essential and care management
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has been shown to impact outcomes, however, additional work needs to be done to determine
sustainability in rural health clinics beyond the quality improvement project period (Wells,
2000). Training as it relates to evidence-based guidelines and development of workflows are
essential for consistent adoptions and improvements to take place in the clinical and community
settings, overcoming the strong pull of providing “usual care”. Further, quality assurance
processes are paramount to ensure that regression to old habits does not occur in the clinical
setting. Additional work needs to be done to understand how the use of technology support the
movement away from usual care and provide the resistance needed to force the sustained
changes needed to improve population health. Further study should be done to evaluate the
qualitative findings that suggest the QI project may have impacted the patient’s social isolation
and support. Lastly, staff satisfaction, engagement and activation should be explored.
Funding
This QI project received no financial support from any funding agency, public, commercial or
not for profit sector organizations.
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Appendices

Appendix A

(“Rural and Non Rural Public Health Regional Networks 2017/2018,” 2017)
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Appendix B

PHQ-9 Screening
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Appendix C
Care Management for Patients with Diabetes and Depression Based on Screening and
Rescreening Results in Primary
Letter of Commitment
Between [Insert practice name here] and Ms. Marcy Doyle, MHS, MSN, RN, CNL
University of New Hampshire Doctorate of Nursing Practice Candidate
This is a letter of commitment (LOC) between the “University of New Hampshire”
hereinafter called UNH and “[practice]”.
I.

Background
•
•
•

•
•
.
II.

Depression is one of the most common treatable and underdiagnosed global
disorders. By 2030 it is predicted to be the second leading cause of disease and
disability worldwide (Mathers & Loncar, 2006).
Individuals with one or more chronic illness have on average between 9.3% and
23.0% increased risk of having comorbid depression (Moussavi et al., 2007).
Sixty-eight percent of patients with a mental illness have a medical condition such
as diabetes leading to functional impairments which results in an inability to
adhere to healthy lifestyle choices, such as, maintaining a balanced diet,
exercising or taking required medications (Moussavi et al., 2007).
IJff et al., (2007) found that only 20 to 40% of depressed adults showed
improvement after twelve months of receiving usual care.
On average, twice as many patients significantly improved when they receive
team-based care collaborative care versus usual care (Unützer et al., 2002).

Project Aims
•
•
•
•
•
•

Establish the level of behavioral health integration at each practice.
Establish the practic’sbaseline depression screening rate.
Establish the practice’s depreesion screening rate in the diabetic practice
population.
Develop an evidencebased clincal workflow/pathway for patients identified as
depressed.
Initiatie comprehensive treatment planning under with a care mangment
component in patients with diabetes and diabetes and a PHQ-9 ≥10
Capture and aggregate physical health metrics (HbA1c, blood pressurme and
body mass index)

III.
Responsibilities
The below tasks will be the responsibility of [insert practice name here].
• Obtain patient consent
• Complete pre-work activities, including identifying QI team members and project lead
collection of baseline evaluation data, and completion of a baseline office system survey.
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•
•
•
•
•
IV.
•
•
•
•

Hold bi weekly check ins with the practice QI team and DNP candidate
Support both the practice and DNP candidate in undertaking the QI project time
Collect and submit monthly data.
Complete a final self-assessment review.
Assist with the development and organization of educational sessions for the project
Benefits of Participation
Learn evidence-based best practices
Develop tools, trainings, technical and quality improvement support to aid in
implementation.
Develop an evidence-based clinical pathway for the practice
Provide staff with additional education on depression and diabetes care and follow-up

We, the undersigned, have read and agree with this Letter of Commitment.

__________________________________
UNH Doctoral of Nursing Practice Candidate

_________________________________
[Practice] Team Leader

Date: October 3, 2017

Date:
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Appendix D Site Self-Asseessment
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Appendix E
CONSENT FORM FOR PARTICIPATION IN A RESEARCH STUDY
RESEARCHER AND TITLE OF STUDY

My name is Marcy Doyle and I am a candidate for Doctor of Nursing Practice at the University
of New Hampshire. I am inviting you to participate in the research study Care Management for
Patients with Diabetes and Depression Based on Screening and Rescreening Results in Primary
Care that I am conducting with other researchers.
WHAT IS THE PURPOSE OF THIS FORM?

This consent form describes the research study and helps you to decide if you want to participate.
It provides important information about what you will be asked to do in the research study, about
the risks and benefits of participating in the research study, and about your rights as a research
participant. You should:
•

Read the information in this document carefully.

•

Ask any questions, particularly if you do not understand something.

•

Not agree to participate until all your questions have been answered, or until you are sure
that you want to.

•

Understand that your participation in this study involves allowing the research team to
use information from your participation in an individualized care management plan for
patients with diabetes and depression. Your information will not be linked to your name;
thus no one will know it is your information.

WHAT IS THE PURPOSE OF THIS STUDY?

The purpose of this study is to learn whether individualized care management plans and more
frequent follow-up with a care team can have positive effects on a patient’s depression and
diabetes. We expect approximately 40 people will participate in the research study. In order to
participate you must be 18 years or older, have diabetes and have symptoms of depression.
WHAT DOES YOUR PARTICIPATION IN THIS STUDY INVOLVE?

In order to participate in the care management program, your depression screening results must
be greater than or equal to a score of 10 which means you have mild to severe major depression.
As part of the care management program, you will be asked to complete the Patient Health
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Questionnaire -9 (PHQ-9) every two weeks for between three to six months. You can complete
the questionnaire, which should take less than two minutes, in the doctor’s office or over the
phone. You may be offered additional care management services based on your individualized
care plan and depression symptoms.
If you choose to participate in the research study, we will use in the study the results from your
PHQ-9 responses and your health measures (blood pressure, body mass index, and hemoglobin
A1c). Each month for between 3 and 6 months, the medical practice will provide me with this
information. Your information will be sent to me without any information that would identify you.
WHAT ARE THE POSSIBLE RISKS OF PARTICIPATING IN THIS STUDY?

Participation in this study is expected to present minimal risks to you.
WHAT ARE THE POSSIBLE BENEFITS OF PARTICIPATING IN THIS STUDY?

There are no anticipated direct benefits to you from participating in this research study. The
research this study may answer the question whether offering short-term case management
services in primary care will improve patient outcomes.
IF YOU CHOOSE TO PARTICIPATE IN THIS STUDY, WILL IT COST YOU ANYTHING?
There are no costs to participate in the research study.
WILL YOU RECEIVE ANY COMPENSATION FOR PARTICIPATING IN THIS STUDY?

Compensation will not be provided as part of the research study.
DO YOU HAVE TO TAKE PART IN THIS STUDY?

Taking part in the research study is completely voluntary. You may choose not to take part at
all. If you decide not to participate in the research study, you will not be penalized or lose any
benefits for which you would otherwise qualify. Your plan of care and treatment will not change
based on whether you chose to participate in the study.
CAN YOU WITHDRAW FROM THIS STUDY?

If you agree to participate in this study and you then change your mind, you may stop
participating at any time. Any data collected as part of your participation will remain part of the
study records. If you decide to stop participating at any time, you will not be penalized or lose
any benefits for which you would otherwise qualify. Your plan of care and treatment will not
change based on whether you chose to participate in the study.
HOW WILL THE CONFIDENTIALITY OF YOUR RECORDS BE PROTECTED?

We plan to maintain the confidentiality of all data and records associated with your participation
in this research. To help protect the confidentiality of your information all research staff will be
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required to comply with the University of New Hampshire and the primary care practice’s
procedures for the storage of data. Data will be de-identified by practices before it is submitted
to the researchers. De-identified data will be stored on UNH Box, (cloud storage). The
information will only be accessible to authorized UNH staff. This staff includes Marcy Doyle,
Jeanne Ryer, EdD, MSc and Dayle Sharp, PhD, DNP, McPh, FNP. A UNH statistician, yet to
be named, will access the de-identified data.
The data from the research study will be reported as a group. Findings may be reported in
publications, presentations or reports. Practices will not be named in any publications or
presentations. The results will be used to understand how to best provide care to patients with
diabetes and depression in rural areas in New Hampshire.
WHOM TO CONTACT IF YOU HAVE QUESTIONS ABOUT THIS STUDY

If you have any questions pertaining to the research you can contact Marcy Doyle at 603-5135288 to discuss them.
If you have questions about your rights as a research subject you can contact Dr. Julie Simpson
in UNH Research Integrity Services, 603/862-2003 or Julie.simpson@unh.edu to discuss them.

Yes, I, __________________________consent/agree to participate in this research project.

No, I, __________________________do not consent/agree to participate in this research project.

___________________________

__________________

39

DEPRESSION SCREENING, DIABETES and CARE MANAGEMENT
Appendix F
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Appendix G
Depression Screening Protocol

41

DEPRESSION SCREENING, DIABETES and CARE MANAGEMENT
Appendix H
Care management protocol and treatment planning notes
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Appendix I
Registry tracking
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